Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Variant survivin vaccine for treatment of myeloma

Variant survivin vaccine for treatment of myeloma

US Patent 12344642 · Granted Jul 1, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of lactoferrin for generating myeloid-derived suppressor cells2025
Oncolytic virus or antigen presenting cell mediated cancer therapy using type I 2025
Use of LRP2 agonists for generating myeloid-derived suppressor cells2024
Aurora kinase and janus kinase inhibitors for prevention of graft versus host di2024
Methods of detecting and treating a tumor expressing pT346 PDK12021
Aurora kinase and Janus kinase inhibitors for prevention of graft versus host di2021
Variant survivin vaccine for treatment of myeloma2021
Variant survivin vaccine for treatment of myeloma2021
Variant survivin vaccine for treatment of myeloma2021
Variant survivin vaccine for treatment of myeloma2021
Variant survivin vaccine for treatment of myeloma2021
Combination immunotherapy for treating cancer2021